3Gillberg PG, Sundquist S, Nilvebrant L. Comparison of the invitro and vivo profiles of tolterodine with those if subtypeselective muscarinic receptors anagonists. EurJ Pharmacol 1998; 349(2): 285-292.
4Chapple CR, Smith D. The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia. BrJUrol 1994; 73(2): 117-123.
5Blok BF. Central pathways controlling micturition and urinary continence. Urology 2002; 59(5 suppl 1): 13-17.
6Zhu G, Xie C, Wang X, eta/. Bipolar plasmakinetic resection of prostate in 132 consecutive patients with large gland: three-year follow-up results. Urology 2012; 79(2): 397-402.
